CRP and non-small cell lung carcinoma: In NSCLC, inflammation (as measured by CRP and neutrophil proportions), alongside serum lactate dehydrogenase and CA125, predict patient responses to chemotherapy (38), radiotherapy (39) and immunotherapy (40).